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Background: Branchio-oto-renal (BOR) syndrome is an autosomal dominant disorder characterized by branchial,
ear, and renal anomalies. The most common gene mutated in BOR patients is EYA1, the human homolog of the
Drosophila eyes absent gene, while mutations in SIX1 gene, the human homolog of sine oculis, encoding a DNA
binding protein interacting with EYA1, have been reported less frequently. Recently, mutations in another SIX family
member, SIX5, have been described in BOR patients, however, this association has not been confirmed by other
groups.
Case presentation: In this study, we have clinically and genetically characterized a proband that displayed hearing
loss, pre-auricular pits, branchial fistulae, hypoplasia of the left kidney, bilateral mild hydronephrosis, progressive
proteinuria and focal glomerulosclerosis. Mutational analysis of EYA1 gene revealed a novel splice site mutation,
c.1475 + 1G > C, that affects EYA1 splicing and produces an aberrant mRNA transcript, lacking exon 15, which is
predicted to encode a truncated protein of 456 aa.
Conclusion: This report provided the functional description of a novel EYA1 splice site mutation and described for
the first time a case of BOR syndrome associated with the atypical renal finding of focal glomerulosclerosis,
highlighting the importance of molecular testing and detailed clinical evaluation to provide accurate diagnosis and
appropriate genetic counselling.
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Branchio-oto-renal (BOR) syndrome (MIM 113650) is an
autosomal dominant disorder characterized by branchial,
ear, and renal anomalies. This syndrome occurs with a
frequency of approximately 1:40,000 in the general popu-
lation and it is found in about 2% of profoundly deaf
children [1]. The major clinical signs are hearing loss,
branchial fistulae and pre-auricular pits, malformations of
the external ear, auditory canal and mid or inner ear,
and renal anomalies ranging from hypoplasia to bilateral
renal agenesis [2]. Other associated clinical manifestations,* Correspondence: mgigante@medicina.unifg.it
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reproduction in any medium, provided the oralthough less frequent, include facial and palate anomalies,
lacrimal duct aplasia and cataracts. In the absence of renal
anomalies, it is defined as Branchio-oto syndrome (BO,
MIM 601653) [3].
The most common gene mutated in BOR patients is
EYA1 (eyes absent homolog 1; MIM 601653) [4], the hu-
man homolog of the Drosophila eyes absent gene. Over
130 different EYA1 disease-causing mutations, resulting in
either BOR or branchial-otic syndrome (BO), have been
published [5-10]. The vertebrate EYA gene family com-
prises four transcriptional activators that ensure normal
branchial arch and epibranchial placode formation and
sensory neurogenesis, including hair cell and neuron for-
mation in the inner ear [11,12]. In the kidney, EYA1 is al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Facial features and renal biopsy. (A) Malformations of
the external ear. (B) Surgical scars of the pre-existing fistulae. (C)
Light microscopy on renal biopsy (Jones’ silver stain, ×400
magnification) showing focal glomerulosclerosis (arrow). (D) Light
microscopy on renal biopsy (PAS stain, ×400 magnification) showing
focal glomerulosclerosis (arrow).
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chyme development [13].
Mutations in SIX1 gene (MIM 601295), the human
homolog of sine oculis, encoding a DNA binding protein
that interacts with EYA1, have also been associated with
BOR syndrome although less frequently than EYA1
mutations [14,15]. Recently, mutations in another SIX
family member, SIX5 (MIM 610896), have been reported
in patients with BOR syndrome [16]. SIX5 homologous
interacts with eya-1 in Caenorhabditis elegans. However,
the association of SIX5 mutations with BOR syndrome
has not been confirmed by other groups and the patho-
genetic role of some SIX5 mutations was reconsider.
BOR syndrome has high penetrance, but incomplete and
variable expressivity. The genetic heterogeneity and the
spectrum of phenotypes associated with different muta-
tions make the diagnosis of BOR sometimes difficult.
Thus, molecular analysis would be a valuable and useful
tool for the confirmation of a clinical diagnosis. Here,
we report the clinical and genetic diagnosis of an Italian
patient with BOR syndrome associated with focal seg-
mental glomerulosclerosis and a novel EYA1 splice site
mutation.
Case presentation
Patient and clinical data
A 27-year old Caucasian man, referred to our Division in
November 2008, underwent to a renal biopsy because of
progressive proteinuria. The patient had a history of
congenital hearing impairment. At the age of 9 years, he
underwent a corrective surgery of pre-auricular fistulae
and lateral fistulae of the neck. At the same time, he was
discovered to have a right auricular malformation, for
which he had a new surgery at the age of 10 years. Urinary
anomalies were first discovered at the age of 21 years. No
cases of deafness, renal diseases, or branchial fistulae were
reported in the patient’s family. Clinical examination
showed surgical scars of the pre-existing fistulae in pre-
auricular site and on both sides of the neck (Figure 1A, B).
A CT scan revealed a complex dysplasia of external,
middle and inner ear, with ossicular dislocation, abnormal
stapedial–ovalar ratio, dysplasic vestibule and incomplete
development of the cochlea of both ears. The external
auditory canals were asymmetric. Audiometric exams
showed a bilateral, mostly conductive hearing loss. La-
boratory values showed serum creatinine of 0.9 mg/dL
with a creatinine clearance of 130.6 mL/min and a pro-
teinuria of 2.5 g/day without microhematuria. Renal ultra-
sound showed hypoplasia of the left kidney and bilateral
mild hydronephrosis, even if the cistography did not show
signs of vesicoureteral reflux. The renal biopsy was
performed with histological pattern compatible with focal
glomerulosclerosis (Figure 1C, D). IgM and C3 deposits
were focally positive.Analysis of EYA1 gene
This study have been performed in accordance with the
Declaration of Helsinki and was approved by the Ethical
Committee of University Hospital in Foggia. Informed
consent for genetic studies was obtained from proband
and all family members. Genomic DNA was purified from
peripheral blood samples of proband and all available fam-
ily members (two siblings and father), using standard pro-
cedures. Mutational analysis of EYA1 gene (NM_000503.4;
GeneID: 2138) was performed by polymerase chain reac-
tion (PCR) and bidirectional sequencing of the coding
Figure 2 EYA1 mutational analysis. (A) Electropherograms of wild type (left) and mutant (right) EYA1 sequences. (B) RNA analysis by RT-PCR on wild
type (WT) and proband fibroblats (Pt): an aberrant transcript of 121 bp was present in Pt line. (C) Electropherograms of wild type transcript. (D) Wild
type cDNA and protein sequence. (E) Electropherograms of aberrant transcript lacking exon 15. (F) Mutant transcript and protein sequences.
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intronic primers were designed using primer3 program
(http://primer3.wi.mit.edu/). PCR products were sequenced
using the Big Dye Terminator v3.1 cycle sequencing
kit on 3130 Genetic Analyzer (Life Technologies, Ltd).
EYA1 mutation was named according to Human Genome
Variation Society recommendations (www.hgvs.org/
mutnomen). The potential effect of splice site mutation
on mRNA splicing was analyzed using Splice Site Predic-
tion server (http://www.fruitfly.org/seq_tools/splice.html).
A skin biopsy was performed in order to get fibroblasts
for RNA analysis. Total RNA was extracted from normal
and proband’s cultured skin fibroblasts by Qiagen’s RNA
Mini Kit (Qiagen) and cDNA was synthesized using
High-Capacity cDNA Reverse Transcription Kit (Life
Technologies, Ltd). RT-PCR and sequencing analysis were
performed by specific primer pairs (F: 50-CCGCTA
CAGACGGGTAAAAG-30; R: 50-CCCATACAGCAGGAC
TTTCG-30) surrounding the region of exon 15.
Sequence analysis of proband revealed a novel EYA1 het-
erozygous mutation in the donor splice site of exon 15,
c.1475 + 1G >C (Figure 2A), which was absent in siblings,
father and 100 healthy controls. Mother blood sample was
not available. Splice Site Prediction server (http://www.
fruitfly.org/seq_tools/splice.html) showed that this change
affects heavily the predicted efficiency of the intron 15
splice donor site (score from 0.98 to 0.00). RNA was
extracted from normal and proband’s cultured skin fibro-
blasts and cDNA was synthesized to identify EYA1 aber-
rant transcripts. cDNA analysis showed that c.1475 + 1G >
C mutation affects EYA1 splicing, producing an aberrant
PCR product of 119 bp lacking exon 15 (Figure 2B, E) re-
spect to the wild type fragment of 241 bp (Figure 2B, C).
The aberrant transcript is predicted to encode an EYA1
truncated protein of 456 aa (Figure 2E) compared to wild
type protein of 592 aa (Figure 2D).
Conclusions
BOR syndrome was first described in 1975 by Melnick
et al. and it is characterized by hearing loss, renal anomal-
ies and branchial cysts or fistulae [17]. Renal abnormalities
are present in 66% of affected individuals, and about 6% of
them progress to renal failure. Major renal alterations in-
clude monolateral renal agenesis, monolateral or bilateral
hypodisplasia and hydronephosis caused by ureteropelvic
obstruction or vesicoureteral reflux [2].
We report here a case of BOR syndrome presenting
typically with bilateral conductive hearing loss, associated
with a complex dysplasia of external, middle and inner
ear; pre-auricular pits; branchial fistulae; hypoplasia of the
left kidney; bilateral mild hydronephrosis and progressive
proteinuria associated with atypical renal histological pat-
tern compatible with focal glomerulosclerosis (Figure 1).
However, in the absence of overt nephrotic syndrome, wecan not exclude a form of secondary focal glomeru-
losclerosis, due to obstructive uropathy related to the
presence of left renal hypoplasia. Mutational analysis of
EYA1 gene revealed a novel EYA1 splice site mutation,
c.1475 + 1G >C, in the donor site of exon 15. RNA ana-
lysis on skin biopsy sample showed that this mutation
affects EYA1 splicing, producing an aberrant mRNA tran-
script, lacking exon 15, that is predicted to encode an
EYA1 truncated protein of 456 aa respect to the wild type
protein of 592 aa (Figure 2). The transcriptional effects of
EYA1 mutations are often unknown due to the difficulty
of obtaining appropriate samples for RNA analysis. To
date, EYA1 transcript analysis have been reported only for
five other patients with BOR syndrome, two of which
presented unstable EYA1 transcripts [8] and three aber-
rant transcripts [15,18]. Clinical features of the latter three
patients included renal hypoplasia, similar to our patient
with the c.1475 + 1G >C mutation, however focal glome-
rulosclerosis associated with IgM and C3 positive im-
munofluorescence was never been reported.
EYA1 is a dual-function transcription factor, with an
amino terminal transcriptional co-activator region that in-
teracts with SIX1 and DACH, and a highly conserved 271
aa carboxy terminal Eya Domain (ED) that dephosphory-
lates SIX1–DACH complexes to switch from repression
[14]. In vivo analysis showed that ED mutations impaired
the catalytic activity (i.e., dephosphorylation) of the EYA1
protein, suggesting that the loss of phosphatase activity
may contribute to impaired EYA1 activity and in turn to
BOR phenotype [19].
The c.1475 + 1G > C mutation produces an aberrant
mRNA transcript that predicts a truncated version of
EYA1 protein containing only 135 aa of the conserved
carboxyterminal Eya domain. The predicted protein
would retain the ability to interact with SIX1–DACH,
but would be unable to dephosphorylate such complexes
to allow gene activation [14]. In agreement with other re-
ports [8,18], our findings confirm that some mutant EYA1
proteins, lacking or with a disrupted phosphatase domain,
might have a dominant-negative gain-of-function activity,
suggesting another possible model for the pathogenesis of
BOR syndrome, in addition to the previously reported
haploinsufficiency model. BOR syndrome is often mis-
diagnosed or not diagnosed in the presence of mild
clinical symptoms [20]. The hearing of BOR children with
malformations of the inner ear can be exacerbated by
minor environment and playground injuries (i.e., head
trauma), as well as nutrition and nephrotoxic drugs might
contribute to kidney failure in patients with kidney
malformations. Our case is an example of a late diagnosis
(27 years) of BOR syndrome, characterized by bilateral con-
ductive hearing loss, bilateral mild hydronephrosis and pro-
gressive proteinuria associated with focal glomerulosclerosis.
An accurate medical history associated with clinical,
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syndrome, even though a more timely clinical and molecular
diagnosis would allow to implement nutritional and lifestyle
strategies that would have prevented the most severe effects
of BOR syndrome. This case suggests the opportunity of
timely researching mutations of EYA1 gene in patient
affected by deafness associated with urinary anomalies and/
or branchial cysts or fistulae.
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